Champions Oncology, Inc. Q3 FY2020 Earnings Call

Champions Oncology, Inc. (CSBR)

Earnings Call FY2020 Q3 Call date: 2020-03-12 Concluded

Quarter scorecard

Revenue

$9.01M

+40.2% YoY

Diluted EPS

$0.03

Net income

$75,000

Pharmacology Services $8.84M

Personalized Oncology Services $169,000

Product And Service Other $0